European Thrombosis and Haemostasis Alliance
Budget
€10 — €0
EP Access
0
accredited persons
Staff
1
0.25 FTE
EU Grants
None
Mission & Goals
The European Thrombosis and Haemostasis Alliance (ETHA) is made up of eminent clinicians and researchers from European national and international societies representing those working in the field of thrombotic and bleeding disorders. We have come together to give the European thrombosis and haemostasis community an allied voice and provide input to EU health and patient safety strategies; make recommendations on EU research programme funding and encourage sharing and adoption of best practices in the treatment and prevention of thrombotic and bleeding disorders across Member States.
EU Legislative Interests
ETHA is interested in Horizon Europe and Horizon 2020 programmes, the EU Cancer Mission, the Europe's Beating Cancer Plan and the Healthier Together Non-Communicable Diseases Initiative. We are also interested in lessons learned from COVID-19. ETHA wants also to focus on European Cardiovascular Health Plan, the European Health Data Space (EHDS), and the Healthier Together Non-Communicable Diseases Initiative.
Communication Activities
- Saving and Improving Lives by Addressing Cancer Associated Thrombosis (policy paper) - ETHA Statement on Lessons learned from COVID-19: the need for better thrombosis management - ETHA contribution to the EU Non-Communicable Diseases Initiative - Cancer-associated venous thromboembolism (VTE) ETHA Report
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
EU Health Policy Platform (HPP) International Society on Thrombosis and Haemostasis (ISTH) European Alliance for Cardiovascular Health (EACH) NCD Alliance
Organisation Members
https://etha.eu/about/
Commissioner Meetings
No recorded meetings with EU commissioners.